Position in LH
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$322,560
+$15,195 QoQ
Shares Held
1,152
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#687
of 1,040 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026CIDEL ASSET MANAGEMENT INC holds $2,829,572 across 6 Diagnostics & Research names. LH ranks #3 (11.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
2,183 | $1,094,468 | |
| 2 | DHR |
Danaher Corp /De/
|
3,675 | $700,014 | |
| 3 | LH |
Labcorp Holdings Inc.
This page
|
1,152 | $322,560 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
1,345 | $259,880 | |
| 5 | DGX |
Quest Diagnostics Inc
|
1,069 | $226,574 | |
| 6 | A |
Agilent Technologies, Inc.
|
1,702 | $226,076 |
All Filings in LH
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $322,560 | 1,152 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $307,365 | 1,152 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $236,078 | 941 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $270,123 | 941 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $247,021 | 941 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $219,008 | 941 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $204,553 | 892 | Shares | Sole | 2025-01-28 | |
| No filing history on record for this holder in this stock. | ||||||